Sérgio Paulo de Magalhães Simões
Chief Executive Officer at Luzitin SA
Sérgio Paulo de Magalhães Simões active positions
| Companies | Position | Start | End |
|---|---|---|---|
Luzitin SA
 Luzitin SA Pharmaceuticals: MajorHealth Technology Luzitin SA provides photodynamic therapy and photodiagnosis solutions. The firm develops new compounds to improve the efficiency of photodynamic therapy in the treatment of cancer. The company was founded by Luís Arnaut in 2010 and is headquartered in Coimbra, Portugal. | Chief Executive Officer | - | - |
| Chairman | - | - | |
Bluepharma Indústria Farmacêutica SA
 Bluepharma Indústria Farmacêutica SA Pharmaceuticals: MajorHealth Technology Bluepharma Indústria Farmacêutica SA develops, manufactures, and markets pharmaceutical drugs The firm operates through the following business areas: Production of Pharmaceutical Drugs for Bluepharma and Other Companies; Research, Development, and Registration of Pharmaceutical Drugs; and Marketing of Generic Pharmaceutical Drugs. Its services include licensing, contract manufacturing, product development, and research and development. The company was founded in February 2001 and is headquartered in Coimbra, Portugal. | Director/Board Member | - | - |
| Corporate Officer/Principal | - | - | |
Biocant Ventures SA
 Biocant Ventures SA Investment ManagersFinance Biocant Ventures SA (Biocant) is an Independent Venture Capital firm founded in 2006. The firm is headquartered in Cantanhede. | Director/Board Member | 31/12/2011 | - |
| Private Equity Investor | 31/12/2011 | - | |
Treat U SA
 Treat U SA BiotechnologyHealth Technology Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal. | Chairman | 31/12/2009 | - |
| Founder | 31/12/2009 | - |
Career history of Sérgio Paulo de Magalhães Simões
Former positions of Sérgio Paulo de Magalhães Simões
| Companies | Position | Start | End |
|---|---|---|---|
| University of Coimbra | Corporate Officer/Principal | - | - |
Training of Sérgio Paulo de Magalhães Simões
| University of Coimbra | Doctorate Degree |
Statistics
International
| Portugal | 6 |
Operational
| Chairman | 2 |
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Luzitin SA
Luzitin SA Pharmaceuticals: MajorHealth Technology Luzitin SA provides photodynamic therapy and photodiagnosis solutions. The firm develops new compounds to improve the efficiency of photodynamic therapy in the treatment of cancer. The company was founded by Luís Arnaut in 2010 and is headquartered in Coimbra, Portugal. | Health Technology |
Bluepharma Indústria Farmacêutica SA
Bluepharma Indústria Farmacêutica SA Pharmaceuticals: MajorHealth Technology Bluepharma Indústria Farmacêutica SA develops, manufactures, and markets pharmaceutical drugs The firm operates through the following business areas: Production of Pharmaceutical Drugs for Bluepharma and Other Companies; Research, Development, and Registration of Pharmaceutical Drugs; and Marketing of Generic Pharmaceutical Drugs. Its services include licensing, contract manufacturing, product development, and research and development. The company was founded in February 2001 and is headquartered in Coimbra, Portugal. | Health Technology |
Biocant Ventures SA
Biocant Ventures SA Investment ManagersFinance Biocant Ventures SA (Biocant) is an Independent Venture Capital firm founded in 2006. The firm is headquartered in Cantanhede. | Finance |
Treat U SA
Treat U SA BiotechnologyHealth Technology Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal. | Health Technology |
